- Brucella abortus induces mast cell activation through TLR-2 and TLR-4
Adriana Dominguez-Flores et al, 2023, Microbial Pathogenesis CrossRef - Advancing the frontiers of adaptive cell therapy: A transformative mechanistic journey from preclinical to clinical settings
Ashi Mannan et al, 2023, International Immunopharmacology CrossRef - Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells
Carmen Mestre-DurĂ¡n et al, 2023, Frontiers in Immunology CrossRef